1. Wolfe JW, Butterworth JF. Local anesthetic systemic toxicity: update on mechanisms and treatment. Curr Opin Anaesthesiol 2011; 24: 561-566. DOI: 10.1097/ACO.0b013e32834a9394.
2.
Garbin M, Benito J, Ruel HLM, Watanabe R, Monteiro BP, Cagnardi P, et al. Pharmacokinetics of bupivacaine following administration by an ultrasound-guided transversus abdominis plane block in cats undergoing ovariohysterectomy. Pharmaceutics 2022; 14: 1548. DOI: 10.3390/pharmaceutics14081548.
3.
Hashizume Y, Yamaguchi S, Mishio M, Takiguchi T, Okuda Y, Kitajima T. Pediatric caudal block with mepivacaine, bupivacaine or a mixture of both drugs: requirement for postoperative analgesia and plasma concentration of local anesthetics. J Clin Anesth 2001; 13: 30-34. DOI: 10.1016/s0952-8180(00)00242-7.
4.
Bielka K, Kuchyn I, Horoshko V. Intensive care units during the Ukraine war: challenges and opportunities. Intensive Care Med 2023; 49: 1011-1014. DOI: 10.1007/s00134-023-07117-5.
5.
El-Boghdadly K, Pawa A, Chin KJ. Local anesthetic systemic toxicity: current perspectives. Local Reg Anesth 2018; 11: 35-44. DOI: 10.2147/LRA.S154512.
6.
De Diego C, Zaballos M, Quintela O, Sevilla R, Callejo D, González-Panizo J, et al. Bupivacaine toxicity increases transmural dispersion of repolarization, developing of a Brugada-like pattern and ventricular arrhythmias, which is reversed by lipid emulsion administration. Study in an experimental porcine model. Cardiovasc Toxicol 2019; 19: 432-440. DOI: 10.1007/s12012-019-09515-y.
7.
Fukuda H, Hirabayashi Y, Shimizu R, Saitoh K, Mitsuhata H. Sevoflurane is equivalent to isoflurane for attenuating bupivacaine-induced arrhythmias and seizures in rats. Anesth Analg 1996; 83: 570-573. DOI: 10.1097/00000539-199609000-00023.
8.
Mauch J, Kutter AP, Martin Jurado O, Spielmann N, Frotzler A, Bettschart-Wolfensberger R, et al. Bupivacaintoxizität und Propofolanästhesie: Tierstudie zur intravasalen Bupivacaininjektion [Bupivacaine toxicity and propofol anesthesia: animal study on intravascular bupivacaine injection]. Anaesthesist 2011; 60: 814-818. DOI: 10.1007/s00101-011-1898-8 [Article in German].
9.
Bozkurt P, Suzer O, Ekici E, Demirci O, Kaya G, Hacibekiroglu M. Effects of bupivacaine used with sevoflurane on the rhythm and contractility in the isolated rat heart. Eur J Anaesthesiol 2003; 20: 199-204. DOI: 10.1017/s0265021503000346.
10.
Ohmura S, Ohta T, Yamamoto K, Kobayashi T. A comparison of the effects of propofol and sevoflurane on the systemic toxicity of intravenous bupivacaine in rats. Anesth Analg 1999; 88: 155-159. DOI: 10.1097/00000539-199901000-00029.
11.
Gaudette F, Benito J, Steagall P, Beaudry F. Assessment of tandem mass spectrometry and high-resolution mass spectrometry for the analysis of bupivacaine in plasma. Biomed Chromatogr 2015; 29: 1724-1730. DOI: 10.1002/bmc.3485.
12.
Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology 1998; 88: 1071-1075. DOI: 10.1097/00000542-199804000-00028.
13.
Güngör İ, Akbaş B, Kaya K, Çelebi H, Tamer U. Sudden developing convulsion during interscalene block: Does propofol anesthesia diminish plasma bupivacaine level? Agri 2015; 27: 54-57. DOI: 10.5505/agri.2015.82160.
14.
Dai AL, Fan LH, Zhang FJ, Yang MJ, Yu J, Wang JK, et al. Effects of sevoflurane preconditioning and postconditioning on rat myocardial stunning in ischemic reperfusion injury. J Zhejiang Univ Sci B 2010; 11: 267-274. DOI: 10.1631/jzus.B0900390.
15.
Lisnyy II, Zakalska KA, Burlaka AA, Lysykh SA, Efimenko OV. Prevention of pathological effect of ischemia-reperfusion in liver resection by sevoflurane preconditioning. Exp Oncol 2023; 45: 252-262. DOI: 10.15407/exp-oncology.2023.02.252.
16.
Bouwman RA, Vreden MJ, Hamdani N, Wassenaar LEJ, Smeding L, Loer SA, et al. Effect of bupivacaine on sevoflurane-induced preconditioning in isolated rat hearts. Eur J Pharmacol 2010; 647: 132-138. DOI: 10.1016/j.ejphar.2010.08.014.
17.
Gantenbein M, Attolini L, Bruguerolle B, Villard PH, Puyoou F, Durand A, et al. Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A. Drug Metab Dispos 2000; 28: 383-385.
18.
Hemeryck A, Belpaire FM. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab 2002; 3: 13-37. DOI: 10.2174/1389200023338017.
19.
Knudsen K, Beckman Suurküla M, Blomberg S, Sjövall J, Edvards-son N. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997; 78: 507-514. DOI: 10.1093/bja/78.5.507.
This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
